Musculocutaneous chronic graft-versus-host disease: MRI follow-up of patients undergoing immunosuppressive therapy

American Journal of Roentgenology

Volumn 192, Issue 5, 2009, Pages 1401-1406

  Horger, Marius ^a   Bethge, Wolfgang ^a   Boss, Andreas ^a   Fenchel, Michael ^a   Claussen, Claus D ^a   Schmalzing, Marc ^a   Vogel, Wichard ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Chronic graft versus host disease; Deep sclerosis; Fasciitis; GVHD; Immunosuppressive therapy; MRI; Superficial sclerosis

Indexed keywords

CYCLOSPORIN; GADOLINIUM PENTETATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYOCUTANEOUS FLAP; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; COMPUTER ASSISTED DIAGNOSIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; MUSCLE DISEASE; SKIN DISEASE; WHOLE BODY IMAGING;

ADULT; AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOSUPPRESSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCULAR DISEASES; PHYSICAL EXAMINATION; SKIN DISEASES; WHOLE BODY IMAGING;

EID: 65649141649     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1699     Document Type: Article

References (10)

1. Penas PF, Jones-Caballero M, Aragues M, et al. Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol 2002; 138:924-934 (Pubitemid 34700739)
2. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Part I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11:945-956 (Pubitemid 41754712)
3. Aractingi S, Chosidow O. Cutaneous graft-versus-host disease. Arch Dermatol 1998; 134:602-612 (Pubitemid 28222313)
4. Pavletic SZ, Martin P, Lee SJ, et al.; Response Criteria Working Group. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Part IV. Response Criteria Working Group report. Biol Blood Marrow Transplant 2006; 12:252-266 (Pubitemid 43273710)
5. Janin A, Socie G, Devergie A, et al. Fasciitis in chronic graft-versus-host disease: a clinicopathologic study of 14 cases. Ann Intern Med 1994; 120:993-998 (Pubitemid 24169278)
6. Rook A, Wilkinson DS, Ebling FJG. Textbook of dermatology, 6th ed. Oxford, UK: Blackwell Science, 1998:2516-2518, 2755-2757
7. van den Bergh V, Tricot G, Fonteyn G, et al. Diffuse fasciitis after bone marrow transplantation. Am J Med 1987; 83:139-143 (Pubitemid 18099038)
8. Markusse HM, Dijkmans BA, Fibbe WE. Eosinophilic fasciitis after allogeneic bone marrow transplantation. J Rheumatol 1990; 17:692-694 (Pubitemid 20201752)
9. Atkinson K. Treatment of extensive human chronic graft-vs-host disease. In: Burakoff SJ, Deeg HJ, Ferrar J, Atkinson K, eds. Graft-vs.-host disease: immunology, pathophysiology, and treatment. New York, NY: Marcel Dekker, 1990:681-690
10. Sullivan KM, Shulman HM, Sorb R, et al. Chronic graft-versus-host disease in fifty-two patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57:267-276 (Pubitemid 11174888)